Stock Taper
SCREENER COMPARE ANY 2 STOCKS
HURA
TUHURA BIOSCIENCES, INC.
NASDAQ
$2.11
▼ DOWN 0.94% (-0.02)

KEY STATISTICS

Market Cap$134.37 M
52w High$3.43
52w Low$0.41
Dividend Yield—
Frequency—
P/E-3.94
Volume99.65K
Shares Out.63.68M

COMPANY

LEADERSHIP

James A. Bianco
CHIEF EXECUTIVE
James A. Bianco

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 22, 2013
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
22

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.—
NOV
13
FRI

SPLIT RECORD

DATETYPERATIO
2024-10-18Reverse1:35
2022-11-14Reverse1:50
2019-05-08Reverse1:10
2016-05-23Reverse1:4

PRICE

$2.11 ▼ DOWN 0.94% (−$0.02)
OVERLAYS
$2.04$2.08$2.129:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.11

About TuHURA Biosciences, Inc.

http://www.tuhurabio.com ↗

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.

INDUSTRY

Biotechnology

A PRODUCT TUHURA BIOSCIENCES, INC. IS KNOWN FOR

IFx-2.0
IFx-2.0

IFx-2.0, TuHURA Biosciences' lead Phase 3 innate immune agonist, aims to overcome resistance to checkpoint inhibitors and is being tested with Keytruda® for advanced Merkel Cell Carcinoma.

COMPETITORS

COMPETITOR
ACET COMPARE
ALXO COMPARE
BNTX COMPARE
CRBU COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 1.7M
IWC
0.02% · 172.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
12.73%
HOLDERS
98
TOP 12 OF 98 · RANKED BY POSITION SIZE
Blackrock, Inc.
2.5M sh · $4.39M
Vanguard Group Inc
2.3M sh · $1.76M
Geode Capital Management, LLC
986.9K sh · $1.77M
Aqr Capital Management LLC
607.2K sh · $1.09M
State Street Corp
512.9K sh · $918.11K
Northern Trust Corp
298.2K sh · $533.75K
Bank Of New York Mellon Corp
211.6K sh · $378.71K
Morgan Stanley
176.2K sh · $133.33K
Apollon Wealth Management, LLC
158.0K sh · $282.84K
Ubs Group AG
141.5K sh · $350.86K
Cetera Investment Advisers
140.2K sh · $251.04K
Suncoast Equity Management
104.4K sh · $186.89K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Laurel Lee
Laurel Lee
Purchase
2025-07-13

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Bianco James A.
Sale · 150.0K shares
2026-05-28
★
DIRECTOR
MANUSO JAMES S J
Purchase · 156.2K shares
2026-02-12
★
DIRECTOR
List Alan
Purchase · 156.2K shares
2026-02-12
★
DIRECTOR
Hoffman Robert E.
Purchase · 156.2K shares
2026-02-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
MARKET OUTPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
Citizens MARKET OUTPERFORM HC Wainwright & Co. BUY Maxim Group BUY

SECTORS PEERS

PEERPRICE
AGEN$7.66COMPARE
IRD$3.69COMPARE
ABOS$2.92COMPARE
SEER$1.98COMPARE
CGTX$1.02COMPARE
INO$1.29COMPARE
SPRO$1.20COMPARE
MCRB$5.11COMPARE